Patent · US Active

Prevention and treatment of obesity

US7763601B2 · kind B2 · utility

0Cited by
9References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 19, 2007
Grant dateJul 27, 2010
Priority date
Expiry dateMar 19, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime (BGP-15) or a pharmaceutically suitable acid addition salt thereof can be used for the prevention or reduction of weight gain or the reduction of the rate of body weight gain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.